You have 9 free searches left this month | for more free features.

Overall Status

Recruiting (13)

Active, not recruiting (5)

Completed (5)

Not yet recruiting (3)

Terminated (1)

Sign in for free

Phase

phase 2 (21)

phase 1 (3)

n/a (1)

phase 1/phase 2 (1)

phase 3 (1)

Study Documents

Intervention Type

drug (27)

other (1)

Funder Type

Industry (14)

Other (13)

Study Type

Interventional (27)

pemigatinib

Showing 26 - 27 of 27

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Endometrial Cancer Trial in Worldwide (retifanlimab, epacadostat, pemigatinib)

Recruiting

Endometrial Cancer

retifanlimab
+4 more

Anchorage, Alaska
+78 more

Jul 25, 2022

Cancer of Unknown Primary Site Trial in Worldwide (Alectinib, Vismodegib, Ipatasertib)

Active, not recruiting

Cancer of Unknown Primary Site

Alectinib
+17 more

Blacktown, New South Wales, Australia
+140 more

Jan 6, 2023